H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...

Scientists at Cornell University have developed a new type of vaccine that may provide stronger and longer-lasting protection ...

With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract allows for robust antibody and T-cell responses where SARS-CoV-2 generally ...

Scientists can deliver genetic material into the body’s cells, turning them into vaccine factories and skipping time-consuming steps such as manufacturing viral proteins or growing the whole ...

As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

The mRNA technology is “the infrastructure needed to build those antiviral vaccines that we use for cancer vaccines.” Another vaccine that is further along in development is OSE2101, ...

Modified live vaccines tend to produce slightly stronger and longer lasting immunity and may provide slightly higher fetal ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

Most pediatric transplant recipients who received live-attenuated viral vaccines after transplant developed protective ...

and La Réunion reported conducting influenza vaccine research in the years 2012 and/or 2013. Lastly, 19 (65%) of the 31 respondent countries reported availability of antiviral drugs for the ...

Inflammation may be at the core of cognitive decline as recent studies offer clues on how herpes simplex virus-1, antibiotics, antivirals, and vaccines may have different effect on dementia risk.